【医脉通•指南】2013+JSH循证临床实践指南：肝细胞癌-更新版-JSH-HCC指南第3版.pdfVIP

bs_bs_banner Hepatology Research 2015; 45: 123–127 doi: 10.1111/hepr.12464 Special Report Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines) Norihiro Kokudo, Kiyoshi Hasegawa, Masaaki Akahane, Hiroshi Igaki, Namiki Izumi, Takafumi Ichida, Shinji Uemoto, Shuichi Kaneko, Seiji Kawasaki, Yonson Ku, Masatoshi Kudo, Shoji Kubo, Tadatoshi Takayama, Ryosuke Tateishi, Takashi Fukuda, Osamu Matsui, Yutaka Matsuyama, Takamichi Murakami, Shigeki Arii, Masatoshi Okazaki and Masatoshi Makuuchi The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan The 3rd version of Clinical Practice Guidelines for Hepatocel- Key words: algorithm for surveillance and diagnosis, lular Carcinoma was revised by the Japan Society of algorithm for treatment, clinical practice guidelines, clinical Hepatology, according to the methodology of evidence-based question, evidence-based medicine medicine, which was published in October 2013 in Japanese. Here, we brie?y describe new or changed recommendations with a special reference to the two algorithms for surveil- lance, diagnosis, and treatment. INTRODUCTION systematically searched scienti?c papers (n = 6750 in total) published between July 2007 and December 2011 HE SECOND VERSION of Evidence-based Clinical in the medical databases (PubMed and Medline) by Practice Guidelines for Hepatocellular Carcinoma T the retrieval styles. The entire published work search (2nd JSH-HCC Guidelines) conducted by the Japan formula is open to the public (https://www.jsh.or.jp/ Society of Hepatology (JSH) was published in 2009 in